Sector: MedicalSuperGen, Inc. (NASDAQ: SUPG)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 23 |
Technical : | 127 |
Performance : | 225 |
Overall: | 108 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 25 |
Technical : | 80 |
Performance : | 251 |
Overall: | 100 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 24 |
Technical : | 127 |
Performance : | 241 |
Overall: | 118 |
Number of Stocks: | 306 |
Headlines
- Investing In The Biotech Sector: Here’s An Easy Way To Profit From Biotech Stocks
Nov 11, 2009 10:44 AM | ARIA, BBI, BMRN, BMY, CELG, IMGN
- SuperGen to Present at Lazard Healthcare Conference on November 18, 2009
Nov 11, 2009 06:00 AM | SUPG
- SuperGen Presentations at AACR-NCI-EORTC
Nov 09, 2009 06:00 AM | SUPG
- SuperGen to Present at Merriman Curhan Ford Investor Summit on November 10, 2009
Nov 04, 2009 06:00 AM | SUPG
- SuperGen Reports 2009 Third Quarter Financial Results
Oct 26, 2009 04:00 PM | SUPG
- Trading Outlook for Peregrine Pharmaceuticals Issued by StockPreacher.com
Oct 26, 2009 06:51 AM | AMGN, HGSI, SGP, SNY, SUPG
- SuperGen and GSK to Collaborate on the Discovery and Development of Novel Epigenetic Therapeutics
Oct 26, 2009 06:00 AM | GSK, SUPG
- SuperGen to Present at BIO Investor Forum on October 29, 2009
Oct 22, 2009 06:00 AM | SUPG
- SuperGen to Announce 2009 Third Quarter Financial Results October 26, 2009
Oct 19, 2009 06:00 AM | SUPG
- StockPreacher.com Issues Trading Outlook for GenVec Inc.
Oct 16, 2009 06:51 AM | BIIB, GNVC, SGMO, SGP, SUPG
- Market Woes Pull Down Local Stocks
Jan 01, 2009 10:21 AM | ASYT, GNLB, GSK, ITRA, PAR, SUPG
- Market Woes Pull Down Local Stocks
Dec 31, 2008 10:05 PM | ASYT, GNLB, GSK, ITRA, SUPG, THOR
- Amgen Co-Founder to Act As Generex Chief Scientific Advisor; Generex Engages Dr. Joseph Rubinfeld to Spearhead the Company's Scientific Development and Commercialization Plans for Its Drug Delivery Platform and Vaccine Technologies
Aug 04, 2009 10:50 AM | AMGN, GNBT, SUPG
- SuperGen’s MP-470 Demonstrates Clinical Benefit in Small Cell Lung Cancer and Neuroendocrine Tumor Patients
Aug 03, 2009 09:11 AM | SUPG
- SuperGen to Present at BMO Healthcare Conference on August 5, 2009
Jul 29, 2009 09:18 AM | SUPG
- SuperGen Reports 2009 Second Quarter Financial Results
Jul 27, 2009 05:03 PM | HSP, SUPG
- SuperGen to Present at Capstone Small-Cap Conference on July 29, 2009
Jul 22, 2009 09:12 AM | SUPG
- SuperGen to Announce 2009 Second Quarter Financial Results July 27, 2009
Jul 21, 2009 09:25 AM | SUPG
- SuperGen Names Mohammad Azab, M.D., Chief Medical Officer
Jul 21, 2009 09:25 AM | SUPG
- SuperGen’s MP-470 Demonstrates Clinical Benefit in Lung Cancer Patients
May 04, 2009 08:18 AM | SUPG
- SuperGen Announces Departure of Chief Medical Officer
May 01, 2009 04:06 PM | SUPG
- SuperGen Reports 2009 First Quarter Financial Results
Apr 27, 2009 04:01 PM | SUPG
- Form 4 SUPERGEN INC For: Oct 23 Filed by: Schonharting Florian (10K)
Oct 26, 2009 12:24 PM
- Form 4 YOUNG MICHAEL D For: Sep 17 (10K)
Sep 21, 2009 10:28 PM
- Form 4 Goldberg Allan R For: Sep 17 (10K)
Sep 21, 2009 10:28 PM
- Form 4 CASAMENTO CHARLES J For: Sep 17 (10K)
Sep 21, 2009 10:27 PM
- Form 4 Schonharting Florian For: Sep 16 (10K)
Sep 18, 2009 06:55 PM
- Form 4 Schonharting Florian For: Sep 14 (10K)
Sep 16, 2009 06:29 PM
- Form 4 Schonharting Florian For: Sep 04 (10K)
Sep 09, 2009 08:02 PM
- Form 4 Schonharting Florian For: Sep 02 (10K)
Sep 04, 2009 08:05 PM
- Form 4 Schonharting Florian For: Aug 31 (10K)
Sep 02, 2009 06:40 PM
- Form 4 Schonharting Florian For: Aug 27 (10K)
Aug 31, 2009 06:14 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
SUPG
|
Compare to S&P
|
| YTD |
42.41 %
|
17.86 %
|
| 4 Weeks |
14.29 %
|
13.05 %
|
| 12 Weeks |
-4.90 %
|
-10.34 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 125.00 %
|
|
EPS Growth in Last Year: 200.00 %
|
|
Sales Growth in Last Quarter: 72.30 %
|
|
Sales Growth in Last Quarter: 1.45 %
|
|
